Will booster doses be required for serogroup B meningococcal vaccine?

The European licensure of 4CMenB, the first vaccine licensed to prevent non-epidemic meningococcal B (MenB) disease, marked an important milestone in the fight against meningococcal disease. However, the potential introduction of 4CMenB into the routine infant schedule is complicated by a number of...

Descrición completa

Detalles Bibliográficos
Main Authors: McQuaid, F, Snape, MD
Formato: Journal article
Idioma:English
Publicado: 2014